OrbiMed’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-266,400	Closed	-$30.8M	–	144
2023 Q3	$30.8M	Sell	266,400 -50,000	-16%	-$5.37M	0.66%	56
2023 Q2	$32.5M	Buy	316,400 +116,400	+58%	+$12.3M	0.59%	55
2023 Q1	$21.8M	Buy	200,000 +29,000	+17%	+$3.21M	0.43%	63
2022 Q4	$19.5M	Buy	+171,000	New	+$14.2M	0.37%	65
2022 Q3	–	Sell	-2,108,555	Closed	-$168K	–	159
2022 Q2	$168K	Sell	2,108,555 -88,000	-4%	-$8.33M	3.06%	4
2022 Q1	$231M	Sell	2,196,555 -303,500	-12%	-$29.6M	3.75%	2
2021 Q4	$269M	Sell	2,500,055 -110,300	-4%	-$12M	3.46%	3
2021 Q3	$286M	Sell	2,610,355 -311,800	-11%	-$32.4M	3.15%	3
2021 Q2	$274M	Sell	2,922,155 -222,200	-7%	-$20.4M	2.77%	7
2021 Q1	$289M	Buy	3,144,355 +135,600	+5%	+$11.4M	2.71%	6
2020 Q4	$220M	Hold	3,008,755	–	–	1.93%	12
2020 Q3	$234M	Buy	3,008,755 +140,845	+5%	+$9.69M	2.95%	6
2020 Q2	$159M	Buy	2,867,910 +526,210	+22%	+$22.5M	2.25%	15
2020 Q1	$69.4M	Buy	2,341,700 +759,400	+48%	+$25.7M	1.17%	31
2019 Q4	$57.3M	Buy	+1,582,300	New	+$48.5M	0.82%	40
2015 Q4	–	Sell	-204,000	Closed	-$4.04M	–	137
2015 Q3	$4.04M	Sell	204,000 -747,000	-79%	-$23.6M	0.04%	111
2015 Q2	$33M	Sell	951,000 -124,000	-12%	-$3.78M	0.28%	67
2015 Q1	$27.9M	Hold	1,075,000	–	–	0.24%	67
2014 Q4	$13.9M	Buy	1,075,000 +179,000	+20%	+$2.24M	0.13%	89
2014 Q3	$11M	Buy	896,000 +350,000	+64%	+$4.07M	0.12%	95
2014 Q2	$8.64M	Buy	546,000 +350,000	+179%	+$5M	0.1%	94
2014 Q1	$2.96M	Buy	+196,000	New	+$2.21M	0.04%	129

Other funds holding HZNP